-
2
-
-
76349088705
-
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and management of ductal carcinoma in situ September 22-24, 2009
-
Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst. 2010;102(3):161-169.
-
(2010)
J Natl Cancer Inst.
, vol.102
, Issue.3
, pp. 161-169
-
-
Allegra, C.J.1
Aberle, D.R.2
Ganschow, P.3
-
3
-
-
0034990786
-
Histological and biological evolution of human premalignant breast disease
-
Allred DC, Mohsin SK, Fuqua SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer. 2001;8(1):47-61.
-
(2001)
Endocr Relat Cancer.
, vol.8
, Issue.1
, pp. 47-61
-
-
Allred, D.C.1
Mohsin, S.K.2
Fuqua, S.A.3
-
4
-
-
0030658933
-
Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find?
-
Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127 (11):1023-1028.
-
(1997)
Ann Intern Med.
, vol.127
, Issue.11
, pp. 1023-1028
-
-
Welch, H.G.1
Black, W.C.2
-
5
-
-
0029121769
-
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
-
Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer. 1995;76(7):1197-1200.
-
(1995)
Cancer.
, vol.76
, Issue.7
, pp. 1197-1200
-
-
Page, D.L.1
Dupont, W.D.2
Rogers, L.W.3
Jensen, R.A.4
Schuyler, P.A.5
-
6
-
-
0020066273
-
Intraductal carcinoma of the breast: Follow-up after biopsy only
-
Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49(4):751-758.
-
(1982)
Cancer.
, vol.49
, Issue.4
, pp. 751-758
-
-
Page, D.L.1
Dupont, W.D.2
Rogers, L.W.3
Landenberger, M.4
-
7
-
-
79960840752
-
Characterizing the impact of 25 years of DCIS treatment
-
Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011;129(1):165-173.
-
(2011)
Breast Cancer Res Treat.
, vol.129
, Issue.1
, pp. 165-173
-
-
Ozanne, E.M.1
Shieh, Y.2
Barnes, J.3
Bouzan, C.4
Hwang, E.S.5
Esserman, L.J.6
-
8
-
-
84880814807
-
Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery
-
Benson JR, Wishart GC. Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol. 2013;14(9):e348-e357.
-
(2013)
Lancet Oncol.
, vol.14
, Issue.9
, pp. e348-e357
-
-
Benson, J.R.1
Wishart, G.C.2
-
9
-
-
79952845819
-
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
-
Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478-488.
-
(2011)
J Natl Cancer Inst.
, vol.103
, Issue.6
, pp. 478-488
-
-
Wapnir, I.L.1
Dignam, J.J.2
Fisher, B.3
-
10
-
-
79851509160
-
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: A meta-analysis
-
Wang S-Y, Shamliyan T, Virnig BA, Kane R. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat. 2011; 127(1):1-14.
-
(2011)
Breast Cancer Res Treat.
, vol.127
, Issue.1
, pp. 1-14
-
-
Wang, S.-Y.1
Shamliyan, T.2
Virnig, B.A.3
Kane, R.4
-
11
-
-
76349106646
-
Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes
-
Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170-178.
-
(2010)
J Natl Cancer Inst.
, vol.102
, Issue.3
, pp. 170-178
-
-
Virnig, B.A.1
Tuttle, T.M.2
Shamliyan, T.3
Kane, R.L.4
-
12
-
-
77951643029
-
NIH state-of-the-science conference statement: Diagnosis and management of ductal carcinoma in situ (DCIS)
-
Allegra CJ, Aberle DR, Ganschow P, et al. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). NIH Consens State Sci Statements. 2009;26(2):1-27.
-
(2009)
NIH Consens State Sci Statements.
, vol.26
, Issue.2
, pp. 1-27
-
-
Allegra, C.J.1
Aberle, D.R.2
Ganschow, P.3
-
14
-
-
33846873244
-
Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models
-
Horton NJ, Kleinman KP. Much ado about nothing: a comparison of missing data methods and software to fit incomplete data regression models. Am Stat. 2007;61(1):79-90.
-
(2007)
Am Stat.
, vol.61
, Issue.1
, pp. 79-90
-
-
Horton, N.J.1
Kleinman, K.P.2
-
15
-
-
84856270792
-
Multiple imputation by chained equations (MICE): Implementation in Stata
-
Royston P, White IR. Multiple imputation by chained equations (MICE): implementation in Stata. J Stat Softw. 2011;45:1-20.
-
(2011)
J Stat Softw.
, vol.45
, pp. 1-20
-
-
Royston, P.1
White, I.R.2
-
16
-
-
0033616909
-
Multiple imputation of missing blood pressure covariates in survival analysis
-
van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med. 1999;18(6): 681-694.
-
(1999)
Stat Med.
, vol.18
, Issue.6
, pp. 681-694
-
-
Van Buuren, S.1
Boshuizen, H.C.2
Knook, D.L.3
-
17
-
-
0000157861
-
Model-based direct adjustment
-
Rosenbaum PR. Model-based direct adjustment. J Am Stat Assoc. 1987;82:387-394.
-
(1987)
J Am Stat Assoc.
, vol.82
, pp. 387-394
-
-
Rosenbaum, P.R.1
-
18
-
-
79958704133
-
An introduction to propensity score methods for reducing the effects of confounding in observational studies
-
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011; 46(3):399-424.
-
(2011)
Multivariate Behav Res.
, vol.46
, Issue.3
, pp. 399-424
-
-
Austin, P.C.1
-
20
-
-
84949193513
-
Reducing bias in observational studies using subclassification on the propensity score
-
Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
-
(1984)
J Am Stat Assoc.
, vol.79
, pp. 516-524
-
-
Rosenbaum, P.R.1
Rubin, D.B.2
-
21
-
-
70350710119
-
Rethinking screening for breast cancer and prostate cancer
-
Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685-1692.
-
(2009)
JAMA.
, vol.302
, Issue.15
, pp. 1685-1692
-
-
Esserman, L.1
Shieh, Y.2
Thompson, I.3
-
22
-
-
84899752622
-
Addressing overdiagnosis and overtreatment in cancer: A prescription for change
-
Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014;15(6):e234-e242.
-
(2014)
Lancet Oncol.
, vol.15
, Issue.6
, pp. e234-e242
-
-
Esserman, L.J.1
Thompson, I.M.2
Reid, B.3
-
24
-
-
84869451873
-
Effect of three decades of screening mammography on breast-cancer incidence
-
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
-
(2012)
N Engl J Med.
, vol.367
, Issue.21
, pp. 1998-2005
-
-
Bleyer, A.1
Welch, H.G.2
-
25
-
-
84864008031
-
Radical prostatectomy versus observation for localized prostate cancer
-
Wilt TJ, Brawer MK, Jones KM, et al; Prostate Cancer Intervention vs Observation Trial (PIVOT) Study Group. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203-213.
-
(2012)
N Engl J Med.
, vol.367
, Issue.3
, pp. 203-213
-
-
Wilt, T.J.1
Brawer, M.K.2
Jones, K.M.3
-
26
-
-
77952054026
-
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis
-
Kerlikowske K, Molinaro AM, Gauthier ML, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010;102(9):627-637.
-
(2010)
J Natl Cancer Inst.
, vol.102
, Issue.9
, pp. 627-637
-
-
Kerlikowske, K.1
Molinaro, A.M.2
Gauthier, M.L.3
-
27
-
-
84877010781
-
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
-
Lazzeroni M, Guerrieri-Gonzaga A, Botteri E, et al. Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype. Br J Cancer. 2013;108(8): 1593-1601.
-
(2013)
Br J Cancer.
, vol.108
, Issue.8
, pp. 1593-1601
-
-
Lazzeroni, M.1
Guerrieri-Gonzaga, A.2
Botteri, E.3
-
28
-
-
84880142464
-
Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively
-
Vandenbussche CJ, Khouri N, Sbaity E, et al. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol. 2013;37(6):913-923.
-
(2013)
Am J Surg Pathol.
, vol.37
, Issue.6
, pp. 913-923
-
-
Vandenbussche, C.J.1
Khouri, N.2
Sbaity, E.3
-
29
-
-
84891771750
-
Ductal carcinoma in situ of the breast: Can biomarkers improve current management?
-
Bartlett JMS, Nofech-Moses S, Rakovitch E. Ductal carcinoma in situ of the breast: can biomarkers improve current management? Clin Chem. 2014;60(1):60-67.
-
(2014)
Clin Chem.
, vol.60
, Issue.1
, pp. 60-67
-
-
Jms, B.1
Nofech-Moses, S.2
Rakovitch, E.3
-
30
-
-
84890427442
-
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
-
Siziopikou KP, Anderson SJ, Cobleigh MA, et al. Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Res Treat. 2013;142(2):415-421.
-
(2013)
Breast Cancer Res Treat.
, vol.142
, Issue.2
, pp. 415-421
-
-
Siziopikou, K.P.1
Anderson, S.J.2
Cobleigh, M.A.3
-
31
-
-
68249114452
-
Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls
-
Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
-
(2009)
BMJ.
, vol.338
, pp. b2393
-
-
Jac, S.1
White, I.R.2
Carlin, J.B.3
-
32
-
-
84864924629
-
Use of imputed population-based cancer registry data as a method of accounting for missing information: Application to estrogen receptor status for breast cancer
-
Howlader N, Noone AM, Yu M, Cronin KA. Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. Am J Epidemiol. 2012;176(4):347-356.
-
(2012)
Am J Epidemiol.
, vol.176
, Issue.4
, pp. 347-356
-
-
Howlader, N.1
Noone, A.M.2
Yu, M.3
Cronin, K.A.4
-
33
-
-
0036673794
-
Use of SEER-Medicare data for measuring cancer surgery
-
Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002; 40(8)(suppl):IV-43-IV-48.
-
(2002)
Med Care.
, vol.40
, Issue.8
, pp. IV43-IV48
-
-
Cooper, G.S.1
Virnig, B.2
Klabunde, C.N.3
Schussler, N.4
Freeman, J.5
Warren, J.L.6
-
34
-
-
84983439853
-
Comparison of SEER treatment data with Medicare claims [published online March 15, 2014]
-
Noone AM, Lund JL, Mariotto A, et al. Comparison of SEER treatment data with Medicare claims [published online March 15, 2014]. Med Care. 2014.
-
(2014)
Med Care.
-
-
Noone, A.M.1
Lund, J.L.2
Mariotto, A.3
|